Ever Source Wealth Advisors, LLC Vir Biotechnology, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 241 shares of VIR stock, worth $1,954. This represents 0.0% of its overall portfolio holdings.
Number of Shares
241
Previous 170
41.76%
Holding current value
$1,954
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VIR
# of Institutions
232Shares Held
90.1MCall Options Held
1.28MPut Options Held
235K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$135 Million1.08% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$133 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$106 Million0.0% of portfolio
-
State Street Corp Boston, MA5.07MShares$41.2 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.22MShares$26.1 Million0.64% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.08B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...